Clopidogrel and the concept of high-risk pharmacokinetics.

Roden DM, Stein CM
Circulation. 2009 119 (16): 2127-30

PMID: 19398674 · DOI:10.1161/CIRCULATIONAHA.109.865907

MeSH Terms (10)

Aryl Hydrocarbon Hydroxylases Clinical Trials as Topic Clopidogrel Cytochrome P-450 CYP2C19 Genetic Variation Humans Pharmacogenetics Platelet Aggregation Inhibitors Risk Factors Ticlopidine

Connections (1)

This publication is referenced by other Labnodes entities: